Lahore, Pakistan ā€“ A groundbreaking study published in the January 2024 issue of the Journal of the Pakistan Medical Association (Volume 74, Issue 1) sheds light on the biochemical factors associated with preeclampsia in primigravida females, providing new avenues for early detection and intervention. The study, titled “Serum resistin and lipid profile in primigravida females with and without preeclampsia: An analytical cross-sectional study,” reveals significant differences in serum resistin levels and lipid profile parameters between pregnant women with and without preeclampsia.

DOI: 10.47391/JPMA.8218

Examining the Biochemical Markers of Preeclampsia

Preeclampsia is a severe medical condition characterized by high blood pressure and signs of damage to another organ system, most often the liver and kidneys. It typically occurs after the 20th week of pregnancy and can have severe implications for both mother and child if left unmanaged. Until now, the pathogenesis of preeclampsia has been incompletely understood, with few reliable biomarkers available for its early detection.

The study, which was conducted at the Department of Physiology and Cell Biology at the University of Health Sciences, Lahore, Pakistan, from 2018 to 2020, compared serum resistin and lipid profile parameters in primigravida females with preeclampsia (group 1) and healthy, normotensive pregnant females (group 2). The study included a total of 80 participants, with 40 women in each group.

Key Findings: Elevated Resistin and Lipid Levels in Preeclampsia

Using enzyme-linked immunosorbent assay for measuring serum resistin levels and colorimetric method for lipid profiling, the researchers found that mean serum resistin levels were significantly higher in the preeclampsia group compared to the normotensive group (p<0.02). Moreover, there were notable differences in the lipid parameters between the two groups, with preeclampsia associated with elevated levels of lipids (pĖ‚0.05).

These results indicate a correlation between higher serum resistin levels, changes in lipid profile, and the incidence of preeclampsia, suggesting that these biochemical markers could potentially be used to predict the risk of developing the condition.

The study authored by Rana Mehwish M., Cheema Mohsin Ali MA, Khan Rida Ajmal RA, Kanwal Asia A, Rana Arshia Mobeen AM, and Lone Khalid Parvez KP, represents a significant stride in understanding the etiology of preeclampsia and exploring potential targets for early detection.

Clinical Implications and Future Research

The results of this study could pave the way for the development of new diagnostic tests that can identify women at risk of preeclampsia earlier in their pregnancies. Early recognition and management of preeclampsia are crucial for the health of both the mother and the baby, potentially averting complications such as HELLP syndrome, eclampsia, preterm birth, and even maternal and infant death.

Future research is required to elucidate the mechanisms underlying the association between resistin, lipid metabolism, and preeclampsia, which may involve inflammation, endothelial dysfunction, and metabolic disturbances. Longitudinal studies following pregnant women from early pregnancy through postpartum would be instrumental in verifying the predictive power of serum resistin and lipid profiles for preeclampsia.

By integrating such biochemical markers into routine prenatal care, healthcare providers could improve pregnancy outcomes through personalized risk management and timely interventions.

Accessibility and Inclusiveness in Research

It is worth noting that the study conducted in Pakistan offers valuable information that contributes to the corpus of global knowledge on preeclampsia, emphasizing the importance of including diverse populations in medical research. The insights gained from such studies can help address healthcare disparities and improve outcomes for pregnant women worldwide.


1. Preeclampsia biomarkers
2. Serum resistin levels
3. Lipid profile pregnancy
4. Primigravida preeclampsia
5. Early detection preeclampsia


Please refer to these primary sources to explore the study and its findings in detail:

1. Rana Mehwish M., Cheema Mohsin Ali MA, Khan Rida Ajmal RA, Kanwal Asia A, Rana Arshia Mobeen AM, Lone Khalid Parvez KP. (2024). Serum resistin and lipid profile in primigravida females with and without preeclampsia: An analytical cross-sectional study. J Pak Med Assoc, 74(1), 62-66. DOI: 10.47391/JPMA.8218

2. American College of Obstetricians and Gynecologists. (2019). Gestational Hypertension and Preeclampsia: ACOG Practice Bulletin, Number 222. Obstetrics & Gynecology, 133(6), e1-e25.

3. Levine, R.J., Maynard, S.E., Qian, C., et al. (2004). Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med, 350(7), 672-683.

4. Thadhani, R., Kisner, T., Hagmann, H., et al. (2016). Pilot study of extracellular vesicles in the urine of pre-eclampsia patients. Nephrol Dial Transplant, 31(6), 949-955.

5. Wang, Y., Zhao, S. (2019). Vascular Biology of Pregnancy. Morgan & Claypool Life Sciences.